These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Erysipelas at the dermatological clinic in Mannheim 1960-1975]. Bertsch O; Bojanovsky A; Jung EG Z Hautkr; 1977 Sep; 52(17):885-9. PubMed ID: 910535 [TBL] [Abstract][Full Text] [Related]
45. [Should NSAID/corticoids be considered when treating erysipelas?]. Jaussaud R; Kaeppler E; Strady C; Beguinot I; Waldner A; Rémy G Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 2):348-51. PubMed ID: 11319363 [TBL] [Abstract][Full Text] [Related]
46. A blistering disease: bullous erysipelas. Edwards J; Green P; Haase D CMAJ; 2006 Aug; 175(3):244. PubMed ID: 16880441 [No Abstract] [Full Text] [Related]
47. [Survey of general practitioners management of erysipelas]. Larivière D; Blavot-Delépine A; Fantin B; Lefort A Rev Med Interne; 2011 Dec; 32(12):730-5. PubMed ID: 21862184 [TBL] [Abstract][Full Text] [Related]
48. Recurrent erysipelas despite antibiotic prophylaxis: an analysis from case studies. Koster JB; Kullberg BJ; van der Meer JW Neth J Med; 2007 Mar; 65(3):89-94. PubMed ID: 17387234 [TBL] [Abstract][Full Text] [Related]
49. [The erysipelas as complication of a lymph oedema after therapy of mastocarcinomas (author's transl)]. Keinert K; Schalldach U; Schumann E Strahlentherapie; 1981 Feb; 157(2):91-3. PubMed ID: 7222137 [TBL] [Abstract][Full Text] [Related]
50. Erysipelas after breast cancer treatment. Naveen KN; Pai VV; Sori T; Kalabhavi S Breast; 2012 Apr; 21(2):218-9. PubMed ID: 21925882 [No Abstract] [Full Text] [Related]
51. [Clinical picture of erysipelas based on material from the Department of Dermatology of the Academy of Medicine in Cracow in 1957-1966]. Kowarz-Sokolowska H; Duszkiewicz J; Malecka A Przegl Dermatol; 1969; 56(5):619-25. PubMed ID: 5362102 [No Abstract] [Full Text] [Related]
52. Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. Lazzarini L; Conti E; Tositti G; de Lalla F J Infect; 2005 Dec; 51(5):383-9. PubMed ID: 16321649 [TBL] [Abstract][Full Text] [Related]
53. [Use of pyrogenal in the combined therapy of erysipelas]. Zhivitsa LV; Zeĭgermakher GA; Knysh EN; Predeina VA Vrach Delo; 1986 Oct; (10):24-6. PubMed ID: 3798883 [No Abstract] [Full Text] [Related]
54. [Hospitalization criteria for erysipelas: prospective study in 145 cases]. Jégou J; Hansmann Y; Chalot F; Roger M; Faivre B; Granel F; Scrivener Y; Cairey-Remonnay S; Bernard P Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 1):375-9. PubMed ID: 12055535 [TBL] [Abstract][Full Text] [Related]
55. [Effectiveness in treating patients with different clinical forms of erysipelas]. Kriukova ZV; Kriukova SA; Panichkina LN Vrach Delo; 1986 Aug; (8):121-2. PubMed ID: 3776149 [No Abstract] [Full Text] [Related]
56. [Gangrenous and phlegmonous erysipelas]. Bartschies GG; Jung HD Z Arztl Fortbild (Jena); 1966 Dec; 60(23):1261-4. PubMed ID: 5998939 [No Abstract] [Full Text] [Related]
57. [Effectiveness of prodigiozan in the complex treatment of erysipelas]. Frolov VM; Rychnev VE Klin Med (Mosk); 1984 Aug; 62(8):123-6. PubMed ID: 6387266 [No Abstract] [Full Text] [Related]
58. [Pathogenesis and principles of conservative and surgical treatment of recurrent erysipelas]. Kosenkov AN; Narenkov VM Khirurgiia (Mosk); 2005; (7):63-5. PubMed ID: 16196162 [No Abstract] [Full Text] [Related]
59. Elements of renal injury in patients with erysipelas. Velciov S; Gluhovschi G; Feier V; Curescu M; Trandafirescu V; Petrică L; Gluhovschi C; Bob F; Bozdog G; Gadalean F; Florescu C; Bobu M; Chiliban A Rom J Intern Med; 2010; 48(2):179-85. PubMed ID: 21428183 [TBL] [Abstract][Full Text] [Related]
60. [Fever therapy of chronic recurring erysipelas]. Ehring F Z Hautkr; 1976 Dec; 51(23):999-1002. PubMed ID: 1007364 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]